|
|
|
|
This Web site is supported by educational grants from Bristol-Myers Squibb and GlaxoSmithKline. |
|
|
|
|
|
|
|
|
|
Home |
 |
|
| Journal Watch Updates! |
| Mutational analysis as a prognostic tool in cytogenetically normal acute myeloid leukemia | | May 8, 2008, 8:29 AM | N Engl J Med | PubMed |
|
| microRNA analysis for prognosis in cytogenetically normal acute myeloid leukemia | | May 8, 2008, 8:29 AM | N Engl J Med | PubMed |
|
| Results from a phase III trial of darbepoetin alfa demonstrate shorter survival and no significant reduction in transfusion occurrence in patients with cancer-related anemia who were not receiving chemotherapy or radiotherapy. | | April 17, 2008, 3:38 PM | J Clin Oncol | PubMed |
|
| High response rates and long-term overall survival were observed in patients with untreated chronic lymphocytic leukemia receiving fludarabine, cyclophosphamide, and rituximab. | | April 17, 2008, 3:37 PM | Blood | PubMed |
|
| An IRIS study subanalysis demonstrated correlation between high imatinib plasma concentrations and good clinical outcomes | | April 16, 2008, 4:09 PM | Blood | PubMed |
|
Read More >> |
|
|
|
|
| What's
New Online! |
 |
March 2008
1 AMA PRA
Category 1 Credit™
Expiration date: April 4, 2009 |
 |
Vol. 6, No. 2
0.5 AMA PRA
Category 1 Credit™
Expiration date: March 3, 2009 |
 |
Vol. 5, No. 4
0.5 AMA PRA
Category 1 Credit™
Expiration date: February 15, 2009 |
|
Current Trends in Leukemia, Lymphoma, and Myeloma
March 7, 2008
Chicago, IL
|
Sixth International Symposium on Supportive Care in Oncology: Cancer Management in the Era of Targeted Agents
February 22-23, 2008
New York, NY
|
12th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myelomas
February 13-17, 2008
Whistler, BC, Canada
|
|
|
|
|